chrisvoncsefalvay/vaers-outcomes huggingface dataset:
CHEST PAIN WHEN BREATHING; INCREASED HEART RATE UPTO 150; TROUBLE SITTING; TROUBLE LAYING DOWN; EXTREME BODY PAIN; TROUBLE WALKING; BACK PAIN; SORENESS AT INJECTION SITE; NAUSEA; THROBBING HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029 expiry: unknown) dose was not reported, administered on 24-MAR-2021 10:35 on left arm for prophylactic vaccination. No concomitant medications were reported. On 24-MAR-2021, the subject experienced chest pain when breathing. On 24-MAR-2021, the subject experienced increased heart rate upto 150. On 24-MAR-2021, the subject experienced trouble sitting. On 24-MAR-2021, the subject experienced trouble laying down. On 24-MAR-2021, the subject experienced extreme body pain. On 24-MAR-2021, the subject experienced trouble walking. On 24-MAR-2021, the subject experienced back pain. On 24-MAR-2021, the subject experienced soreness at injection site. On 24-MAR-2021, the subject experienced nausea. On 24-MAR-2021, the subject experienced throbbing headache. Laboratory data included: Heart rate (NR: not provided) 150 (units unspecified). Laboratory data (dates unspecified) included: Chest X-ray (NR: not provided) UNKNOWN (units unspecified). Treatment medications (dates unspecified) included: ondansetron, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from throbbing headache, nausea, extreme body pain, increased heart rate upto 150, soreness at injection site, trouble walking, trouble sitting, trouble laying down, chest pain when breathing, and back pain. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as the case assessed as non-serious.
16y/o M received  MENVEO, flu, and TB test. Patient felt lightheaded, look pale, and had clammy hands after getting the vaccines. Stiffness reported in both hands, and right leg. Also, felt stiffness at his mouth and could not talk. Had patient lay down, vital sign taken.  MD assessed patient, total time to get back on his normal baseline is about an hour.
Patient had sporadic rash on chest noted prior to immunization administration. Approx. 20 min following administration mother called stating patient's cheeks were swollen and patient was coughing. Advised mother to return to clinic with patient. Arrived approx. 5 min later and patient was examined by Dr. ZYRTEC administered per wt/age. O2 sat 98%. Care resumed by Dr.
Pt had cough, vomiting, choking after first drops of Rotateq. Did not give full dose of vaccine. Pt continued to vomit, was referred to ER.
Patient's physician ordered Pneumococcal 23 but was given Prevnar 20 instead. The error was realized and the patient was called back to the clinic where side effects of all the pneumococcal vaccines were discussed, as well as recommendations to get either Pneumococcal 23 or conjugated pneumococcal 13 in 2 years. The patient did not have adverse effects from the incorrect vaccine administration.
pt recv vax 30JUN98 & next day 1jUL98 pt devel a rash;
Pt's arm has a red spot at injection site. She complained of it being itchy and painful to touch. She is allergic to antihistamines, so it was recommended that she use some Cortizone cream and follow up with her doctor if the area did not get better or worsened within a couple of days.
EMPLOYEE WAS GIVEN SECOMD DOSE OF MODERNA BUT SHOULD HAVE RECIEVED PFIZER.
4/30/21 -evening of the vaccine selling in the arm at the site of the vaccine and headache, the next day5/1/21, started with body aches; sore throat and swollen lymph nodes. This morning 5/6/21 she notice a fever of 100degrees for the first time. She had been taking 800 mg of ibuprofen since she got her vaccine.
Shivering, chills, freezing feeling after a few hours started feeling burning hot all over body with violent joint and muscle pain and numbing sensation fingertips. Unbelievable injection site pain and swelling. Felt like going to die!
Fever; Severe chills from the waist up; Feeling achey; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Severe chills from the waist up) and MYALGIA (Feeling achey) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced PYREXIA (Fever), CHILLS (Severe chills from the waist up) and MYALGIA (Feeling achey). At the time of the report, PYREXIA (Fever), CHILLS (Severe chills from the waist up) and MYALGIA (Feeling achey) outcome was unknown.            Concomitant Products include unspecified Blood Pressure medication
JOINT PAIN, MUSCLE, TENDON PAIN, VERY SEVERE. SEEEMS TO BE SLOWLY RESOLVING, BUT SEVERE PAIN CONTINUES IN SHOUJLDERS AND BACKS OF LEGS. PAIN CONTROLLED WITH ADVIL AND TYLENOL EVERY DAY.  PATIENT HAS HAD ALL MODERNA COVID VACCINES OFFERED WITH NO ABNORMAL REACTIONS. ALSO HAS HAD PNEUMONIA, SHINGLES, FLU, TDAP AS APPROPRIATE WITH NO ADVERSE REACTIONS.
(L) upper arm swelling, pain & fatigue 1-2 d. after vaccination then supraclavicular node noted ipsilateral about 4 days later low grade fever also noted. Seen in office 12/17/18 and started on Cefdinir with subsequent resolution but lymph node took few weeks for resolution.
Patient states approximately 3 hrs after injection she had headache, body aches, chills. States she had 101-102 degree fever, responsive to TYLENOL (99).
left hand was flopping like someone had a stroke; no control over his hand or fingers; he had the Pfizer booster shot yesterday; This is a spontaneous report from contactable consumer. 87-years-old male patient received bnt162b2 (BNT162B2), dose 3 (booster shot) via an unspecified route of administration, administered in Arm Left on 29Aug2021 14:00 (Batch/Lot number was not reported) as a single dose for covid-19 immunisation. Medical history included 12 years ago that he had heart surgery and it worked and his heart works. Concomitant medications were not reported.  Stated that that he had the Pfizer booster shot yesterday (29Aug2021), that it was refrigerated yesterday and they had to mix it which he did not know that they had to do. Stated that he got the first two shots in (withheld) in large campus like environment. Stated that he is fine, can open and close fist. Stated that they may want to send him to someone to perform exercises.Caller reports he received the booster dose 29Aug2021 at 1400. Caller says "I would say I am in good health". Caller received his booster dose in his left arm; he reports on 30Aug2021, his left hand was flopping around like someone who has had a stroke, he had no control over his hand or fingers. He reports the "flopping" has resolved today and he wanted to know if this side effect had been reported. Caller wants to know if he is an outlier with this side effect and wanted to ensure he reported this side effect. The outcome of the events was recovered on the same day, while the booster dose was unknown.          The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up. .
Evening of shot very tired and achy.  11/06-site of shot red and sore, size of 2 inch diameter.  Morning of 11/07, red rash on chest at base of throat to breasts.  Itching on neck, arms, shoulders.  Called MD to report. Purchased generic Benadryl, took twice and itching and rash went away.  Knot in arm where shot given gone by 11/09.  First time I had flu shot. Follow up on 12/08/2003: "Unknown to me, please contact health department."
Patient came in to receive first dose of Covid-19 primary series. After technician vaccinated patient, we realized she actually received the booster dose instead of the primary dose. Patient stayed in the waiting room for 15 minutes after vaccination to ensure no adverse reactions. Patient was fine.
After receiving MMR vaccine at 15 month check up began exhibiting sever changes in behavior, severe meltdowns, would run away from teachers, would not participate in class activities, loss of eye contact with parents/teacher, family members, began walking on tip-toes.  He could not transition during any type of change in activity at home or school, would run around house with a high pitched scream.  He would line up his toys or tear them up and play with them in an inappropriate manner.  He also would want to watch the same movie over and over - in an obsessive manner.  He also would flap his hands.  We observed all of these characteristics at age 3, I had him formally diagnosed by a doctor with Asperger's Syndrome, an autism spectrum disorder, February 2004. 5/8/06 Received medical records from PCP which indicate patient experienced allergies to peanuts, eggs, cats & oak trees, frequent cough, eczema, hives, OM & bronchitis & multiple episodes of staph/strep skin infections. Tx by allergist, neuropsychologist (for toe walking) who dx w/Aspergers 4/04 and GI doctor who dx w/diarrhea & feeding difficulties despite eliminating dairy, gluten & soy.  Unable to obtain records from neuropsychologist despite multiple requests/ss. 60 Day Follow-up Information 16-JUN-2006: He still has a diagnosis of Asberger's Syndrome but has much less severe O.C.D. behaviors as when he was 1 1/2 - 2 yrs of age and socially acts appropriately now. Patient has improved drastically in all areas due to a specialized preschool for the past 2 years, sensory integration, gluten-free/casein-free diet, vitamin supplementation, etc, but some times he has some unruly behavior but it may be due to him being 5 and 1/2 years old, and not Asberger's Syndrome.
2 7/8" x 2 1/2" red, raised, hot area on left arm. Very painful.
P/receiving a dose of Td, pt devel a sore, edematous (edema 2+) lt arm from the shoulder to the elbow, w/massive redness;
This spontaneous report as received from a health professional refers to a 12 months old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 18-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sudden Cardiac Arrest . Resuscitated and transferred to the hospital. Never regained consciousness and died on 5/11/21.
Pt experienced a large, red, swollen area moving down arm, a 3" nodule and mild nausea for 2 days.
Initial report received from a health care professional on 7/26/05. A 20 year old female patient had received a first dose of Menactra, lot number U1657AA, administered in the left deltoid on 7/21/05. One day later, she developed a severe headache and a fever of 105 degrees F. She also had a 5cm area of induration at the injection site. The patient was seen in the physician's office on 7/26/05, where it was noted that her left deltoid was red and warm to touch. The patient was advised to use ice on the injection site and to take ibuprofen. At the time of the office visit, the patient's headache had resolved and she was feeling better. She has since recovered from the events. (OMIC)
Swollen, reddened area at inj. site on left arm - took BENADRYL and CLARITIN.
7-10-07 Tem 99-100 7-17-07 Tem 103, abd pain-Lasting 40 7-31-07 No temp/no discomfort
Can not sleep; Swollen arm; At first there was one bump at the injection site, now there is three bumps.; Arm is really sore; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE NODULE (At first there was one bump at the injection site, now there is three bumps.), PAIN IN EXTREMITY (Arm is really sore) and INSOMNIA (Can not sleep) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032AZI and 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE NODULE (At first there was one bump at the injection site, now there is three bumps.) and PAIN IN EXTREMITY (Arm is really sore). On an unknown date, the patient experienced INSOMNIA (Can not sleep). The patient was treated with PARACETAMOL (TYLENOL) for Pain in extremity, at a dose of 400 mg and MELOXICAM (MOBIC) for Pain in extremity, at a dose of 7.5 mg. At the time of the report, PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE NODULE (At first there was one bump at the injection site, now there is three bumps.) and PAIN IN EXTREMITY (Arm is really sore) had not resolved and INSOMNIA (Can not sleep) outcome was unknown.            Patient received Pfizer paperwork but did not receive the Pfizer covid vaccine.  Concomitant product use was not provided by the reporter.  Action taken with mRNA-1273 in response to the events was not Applicable.
Patient developed swelling and pain at the vaccine sites, especially above right arm above meningococcal B was placed. He developed a headache that night with a fever of 102F. His mother was giving him Tylenol for the pain. Next night and again following morning and afternoon 02/18/20. He started talking Motrin on 2/19/20 for the pain as per phone call with his mother. His mother also reported that he started to feel better that day.
Information has been received from a physician concerning a 22 year old female patient who on 15-JUN-2007, was vaccinated IM with a first dose of Gardasil. A few minutes later the patient started sweating profusely and became nauseous. The patient also complained that the injection hurt when she was getting it. No medical attention was sought. No laboratory diagnostic studies were performed. Within 5 minutes, the patient recovered. No product quality complaint was involved. Additional information has been requested.
swelling of her lips and hoarseness of voice as she had mild throat swelling.  She treated self with albuterol inhaler as had some chest tightness. She was seen 80 minutes after injection and given diphenhydramine 50  mg and monitored for 2.5 hours. VS remained stable although mild elevated blood pressure. !70
Body aches, fever, vomiting, extreme diarrhea, dehydration,chills,headache
2x3 reddened, slight indurated area. Right arm. No itch. Ice and Benadryl if needed.
high fever rapid heart rate body aches headache chills vomitting diarrhea dehydration
Contracted COVID-19 11 days after first jab; Contacted COVID-19 11 days after first jab; This is a spontaneous report from a contactable nurse (patient) via a Pfizer sales representative. A patient of unspecified age and gender received the first dose of bnt162b2 (BNT162B2) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient contracted COVID-19 11 days after first jab. Outcome of the event was unknown.  Information about Lot/Batch number is requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be excluded for reported events.
After I received me second vaccine, I woke up overnight with a fever of 102 I think it was, I took some Tylenol to help with that so I could sleep. Then my lymph nodes at the base of my neck where it meets my shoulder swelled up on both sides, but more significantly in my left side where I got the vaccine. It was painful to the touch. I called my doctor and she had me come in. She said it was a potential side effect of the vaccine but it was on the extreme side of it. She advised me to continue taking Tylenol or Advil, which I did do. And if the swelling was bad to use warm compresses. And if the swelling didn't go down in within 2 weeks to follow up with her. It went away in about a week roughly. I ended up missing 2 days of work when I had the fever. I had to wait for it to go down because that was the policy where I work at and also I was so uncomfortable and felt miserable.
Feeling like he is getting a cold; This is a spontaneous report received from a contactable pharmacist (patient's friend).  A 63-year-old male patient received BNT162B2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious) with onset 31Mar2021, outcome "unknown", described as "Feeling like he is getting a cold".  Additional Information: The patient had the first shot dose of the Pfizer COVID-19 vaccine 3 weeks ago. The pharmacist was calling on behalf of the patient who is feeling like he is getting a cold (feels like he is coming out with cold) today (31Mar2021) before he gets the second dose tomorrow. The patient was scheduled to get his second dose tomorrow (also reported as the day of the reporting - 31Mar2021).   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rash to face and neck approx. 12 hours after vaccination. Also reported chills, body aches, headache, feeling feverish, dizziness and fatigue after.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 31-JAN-2017 at 10:56, the patient was vaccinated with improperly stored VARIVAX injection (lot # M035142) (expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000407: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704.
Information has been received from a nurse referring to an unspecified number of patients of unknown age and gender. These patients were administered an unspecified number of improperly stored doses of GARDASIL (lot# K006960, expiration 19-FEB-2017, dose was not reported) intramuscularly on unspecified dates since 02-APR-2015. No adverse effect was reported. Additional information has been requested.
experienced pain; swelling on her right side and in her joints; swelling on her right side and in her joints; The pain and swelling is located mostly in her knees; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- unknown) via an unspecified route of administration on 21May2021 as 2nd dose, single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- unknown) via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunization. It was reported that patient received both doses of Pfizer Covid 19 vaccine. Her last dose was on 21May2021. She had experienced pain and swelling on her right side and in her joints. The pain and swelling was located mostly in her knees and the pain began on her right side and then moved to her left side. The swelling was now on both sides. She wanted to know how long swelling and pain will last. The outcome of the events was unknown.  Information about lot/batch number is expected.
As of 9/6/2021: Case is currently hospitalized. She is still having symptoms. They began last Sunday and she got tested when she developed a fever and she had low oxygen so they admitted her to hospital.
Swelling and itching at injection size.  The swelling is the size of a gold ball
patient passed out right after receiving immunization, pharmacist provided ice pack, lifted feet, gave water once patient came-to. This is a usual effect from all vaccines according to the spouse.
Information has been received from a nurse practitioner concerning a few patients who were vaccinated with the second dose of Rotateq between 11 and 13 weeks after the first dose. All of the patient received the third dose by 32 weeks. The reporter did not have the individual patient information. No further information is available. Follow up information indicated that no child had an adverse experience following the Rotateq. No additional information is expected.